Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1969 Mar;45(521):196–201. doi: 10.1136/pgmj.45.521.196

Developments in jaundice.

R P Thompson, R Williams
PMCID: PMC2466812  PMID: 5785429

Full text

PDF
196

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADLERCREUTZ H. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Oct 31;2(5417):1133–1133. [PMC free article] [PubMed] [Google Scholar]
  2. BORGLIN N. E. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1965 May 15;1(5445):1289–1290. doi: 10.1136/bmj.1.5445.1289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bishop P. M. Oral contraceptives. Practitioner. 1968 Jan;200(195):121–128. [PubMed] [Google Scholar]
  4. Brown J. B., Blair H. A. Urinary OEstrogen Metabolites of 19-Norethisterone and its Esters [Summary]. Proc R Soc Med. 1960 Jun;53(6):433–433. doi: 10.1177/003591576005300611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COHN M. Contributions of studies on the beta-galactosidase of Escherichia coli to our understanding of enzyme synthesis. Bacteriol Rev. 1957 Sep;21(3):140–168. doi: 10.1128/br.21.3.140-168.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COMBES B., SHIBATA H., ADAMS R., MITCHELL B. D., TRAMMELL V. ALTERATIONS IN SULFOBROMOPHTHALEIN SODIUM-REMOVAL MECHANISMS FROM BLOOD DURING NORMAL PREGNANCY. J Clin Invest. 1963 Sep;42:1431–1442. doi: 10.1172/JCI104828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CONNEY A. H., MILLER E. C., MILLER J. A. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res. 1956 Jun;16(5):450–459. [PubMed] [Google Scholar]
  8. Cooper J. M., Kellie A. E. The metabolism of megestrol acetate (17-alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione) in women. Steroids. 1968 Feb;11(2):133–149. doi: 10.1016/0039-128x(68)90004-4. [DOI] [PubMed] [Google Scholar]
  9. Cunningham M. D., Kelley L. R., Peters E. R. Phenobarbitone in cholestasis. Lancet. 1968 May 18;1(7551):1089–1089. doi: 10.1016/s0140-6736(68)91437-2. [DOI] [PubMed] [Google Scholar]
  10. DeLeon A., Gartner L. M., Arias I. M. The effect of phenobarbital on hyperbilirubinemia in glucuronyl transferase deficient rats. J Lab Clin Med. 1967 Aug;70(2):273–278. [PubMed] [Google Scholar]
  11. EISALO A., JAERVINEN P. A., LUUKKAINEN T. HEPATIC IMPAIRMENT DURING THE INTAKE OF CONTRACEPTIVE PILLS: CLINICAL TRIAL WITH POSTMENOPAUSAL WOMEN. Br Med J. 1964 Aug 15;2(5406):426–427. doi: 10.1136/bmj.2.5406.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. EISALO A., JAERVINEN P. A., LUUKKAINEN T. LIVER-FUNCTION TESTS DURING INTAKE OF CONTRACEPTIVE TABLETS IN PRE-MENOPAUSAL WOMEN. Br Med J. 1965 May 29;1(5447):1416–1417. doi: 10.1136/bmj.1.5447.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gallagher T. F., Jr, Mueller M. N., Kappas A. Estrogen pharmacology. IV. Studies of the structural basis for estrogen-induced impairment of liver function. Medicine (Baltimore) 1966 Nov;45(6):471–479. [PubMed] [Google Scholar]
  14. HART L. G., ADAMSON R. H., DIXON R. L., FOUTS J. R. Stimulation of hepatic microsomal drug metabolism in the newborn and fetal rabbit. J Pharmacol Exp Ther. 1962 Jul;137:103–106. [PubMed] [Google Scholar]
  15. KLEINER G. J., KRESCH L., ARIAS I. M. STUDIES ON HEPATIC EXCRETARY FUNCTION. II. THE EFFECT OF NORETHYNODREL AND MESTRANOL ON BROMSULFALIEN SODIUM METABOLISM IN WOMEN OF CHILDBEARING AGE. N Engl J Med. 1965 Aug 19;273:420–423. doi: 10.1056/NEJM196508192730804. [DOI] [PubMed] [Google Scholar]
  16. Kappas A. Biologic actions of some natural steroids on the liver. N Engl J Med. 1968 Feb 15;278(7):378–384. doi: 10.1056/NEJM196802152780707. [DOI] [PubMed] [Google Scholar]
  17. Kreek M. J., Weser E., Sleisenger M. H., Jeffries G. H. Idiopathic cholestasis of pregnancy. The response to challenge with the synthetic estrogen, ethinyl estradiol. N Engl J Med. 1967 Dec 28;277(26):1391–1395. doi: 10.1056/NEJM196712282772603. [DOI] [PubMed] [Google Scholar]
  18. Larsson-Cohn U., Stenram U. Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents. Acta Med Scand. 1967 Mar;181(3):257–264. doi: 10.1111/j.0954-6820.1967.tb15151.x. [DOI] [PubMed] [Google Scholar]
  19. MARQUARDT G. H., FISHER C. I., LEVY P., DOWBEN R. M. Effect of anabolic steroids on liver function tests and creatine excretion. JAMA. 1961 Mar 11;175:851–853. doi: 10.1001/jama.1961.03040100015005. [DOI] [PubMed] [Google Scholar]
  20. METGE W. R., OWEN C. A., Jr, FOULK W. T., HOFFMANN H. N., 2nd BILIRUBIN GLUCURONYL TRANSFERASE ACTIVITY IN LIVER DISEASE. J Lab Clin Med. 1964 Jul;64:89–98. [PubMed] [Google Scholar]
  21. MUELLER M. N., KAPPAS A. ESTROGEN PHARMACOLOGY. I. THE INFLUENCE OF ESTRADIOL AND ESTRIOL ON HEPATIC DISPOSAL OF SULFOBROMOPHTHALEIN (BSP) IN MAN. J Clin Invest. 1964 Oct;43:1905–1914. doi: 10.1172/JCI105064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Martinez-Manautou J., Giner-Velasquez J., Cortes-Gallegos V., Aznar R., Rojas B., Guitterez-Najar A., Rudel H. W. Daily progestogen for contraception: a clinical study. Br Med J. 1967 Jun 17;2(5554):730–732. doi: 10.1136/bmj.2.5554.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ockner R. K., Davidson C. S. Hepatic effects of oral contraceptives. N Engl J Med. 1967 Feb 9;276(6):331–334. doi: 10.1056/NEJM196702092760607. [DOI] [PubMed] [Google Scholar]
  24. Odell G. B. "Physiologic" hyperbilirubinemia in the neonatal period. N Engl J Med. 1967 Jul 27;277(4):193–195. doi: 10.1056/NEJM196707272770406. [DOI] [PubMed] [Google Scholar]
  25. PAULSEN C. A. PROGESTIN METABOLISM: SPECIAL REFERENCE TO ESTROGENIC PATHWAYS. Metabolism. 1965 Mar;14:SUPPL–SUPPL:319. doi: 10.1016/0026-0495(65)90018-1. [DOI] [PubMed] [Google Scholar]
  26. PEREZ-MERA R. A., SHIELDS C. E. Jaundice associated with norethindrone acetate therapy. N Engl J Med. 1962 Nov 29;267:1137–1138. doi: 10.1056/NEJM196211292672208. [DOI] [PubMed] [Google Scholar]
  27. REMMER H., MERKER H. J. DRUG-INDUCED CHANGES IN THE LIVER ENDOPLASMIC RETICULUM: ASSOCIATION WITH DRUG-METABOLIZING ENZYMES. Science. 1963 Dec 27;142(3600):1657–1658. doi: 10.1126/science.142.3600.1657. [DOI] [PubMed] [Google Scholar]
  28. RICE-WRAY E. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Oct 17;2(5415):1011–1011. doi: 10.1136/bmj.2.5415.1011-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Remmer H., Schenkman J., Estabrook R. W., Sasame H., Gillette J., Narasimhulu S., Cooper D. Y., Rosenthal O. Drug interaction with hepatic microsomal cytochrome. Mol Pharmacol. 1966 Mar;2(2):187–190. [PubMed] [Google Scholar]
  30. Roberts R. J., Plaa G. L. Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol. 1967 May;16(5):827–835. doi: 10.1016/0006-2952(67)90055-x. [DOI] [PubMed] [Google Scholar]
  31. Robinson S. H., Lester R., Crigler J. F., Jr, Tsong M. Early-labeled peak of bile pigment in man. Studies with glycine-14C and delta-aminolevulinic acid-3H. N Engl J Med. 1967 Dec 21;277(25):1323–1329. doi: 10.1056/NEJM196712212772501. [DOI] [PubMed] [Google Scholar]
  32. SWAAB L. I. ORAL CONTRACEPTIVES AND LIVER DAMAGE. Br Med J. 1964 Sep 19;2(5411):755–755. doi: 10.1136/bmj.2.5411.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. SWYER G. I., LITTLE V. ABSENCE OF HEPATIC IMPAIRMENT IN LONG-TERM ORAL-CONTRACEPTIVE USERS. Br Med J. 1965 May 29;1(5447):1412–1414. doi: 10.1136/bmj.1.5447.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schaffner F. The effect of oral contraceptives on the liver. JAMA. 1966 Nov 28;198(9):1019–1021. [PubMed] [Google Scholar]
  35. Schmid R., Marver H. S., Hammaker L. Enhanced formation of rapidly labelled bilirubin by phenobarbital: hepatic microsomal cytochromes as a possible source. Biochem Biophys Res Commun. 1966 Aug 12;24(3):319–328. doi: 10.1016/0006-291x(66)90158-6. [DOI] [PubMed] [Google Scholar]
  36. Somayaji B. N., Paton A., Price J. H., Harris A. W., Flewett T. H. Norethisterone jaundice in two sisters. Br Med J. 1968 May 4;2(5600):281–283. doi: 10.1136/bmj.2.5600.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. TYLER E. T. EIGHT YEARS' EXPERIENCE WITH ORAL CONTRACEPTION AND AN ANALYSIS OF USE OF LOW-DOSAGE NORETHISTERONE. Br Med J. 1964 Oct 3;2(5413):843–847. doi: 10.1136/bmj.2.5413.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Thompson R. P., Williams R. Treatment of chronic intrahepatic cholestasis with phenobarbitone. Lancet. 1967 Sep 23;2(7517):646–648. doi: 10.1016/s0140-6736(67)90688-5. [DOI] [PubMed] [Google Scholar]
  39. Urban E., Frank B. W., Kern F., Jr Liver dysfunction with mestranol but not with norethynodrel in a patient with Enovid-induced jaundice. Ann Intern Med. 1968 Mar;68(3):598–602. doi: 10.7326/0003-4819-68-3-598. [DOI] [PubMed] [Google Scholar]
  40. Vesell E. S. Induction of drug-metabolizing enzymes in liver microsomes of mice and rats by softwood bedding. Science. 1967 Sep 1;157(3792):1057–1058. doi: 10.1126/science.157.3792.1057. [DOI] [PubMed] [Google Scholar]
  41. WHEELER H. O., EPSTEIN R. M., ROBINSON R. R., SNELL E. S. Hepatic storage and excretion of sulfobromophthalein sodium in the dog. J Clin Invest. 1960 Feb;39:236–247. doi: 10.1172/JCI104034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yaffe S. J., Levy G., Matsuzawa T., Baliah T. Enhancement of glucuronide-conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. N Engl J Med. 1966 Dec 29;275(26):1461–1466. doi: 10.1056/NEJM196612292752602. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES